Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019: A content analysis
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2024.105155
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Guo, Lin & Sang, Bin & Zhang, Linlin & Yin, Wenqiang & Yuan, Xiaoping & Ma, Chunxiao, 2024. "Easing caregiver strain: The power of health check-ups," Social Science & Medicine, Elsevier, vol. 362(C).
- ., 2024. "Mapping the new methodological terrain," Chapters, in: The Atlas of Social Complexity, chapter 30, pages 416-445, Edward Elgar Publishing.
- Moriarty, Frank & Larkin, James & Fahey, Tom, 2021. "Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study," Health Policy, Elsevier, vol. 125(10), pages 1297-1304.
- Xinming Du & Shan Zhang & Eric Zou, 2024.
"Marine Microplastics and Infant Health,"
NBER Working Papers
33094, National Bureau of Economic Research, Inc.
- Xinming Du & Shan Zhang & Eric Zou, 2024. "Marine Microplastics and Infant Health," Papers 2410.17391, arXiv.org.
- BÃró, A.; & Elek, P.;, 2024. "Firm Quality and Health Maintenance," Health, Econometrics and Data Group (HEDG) Working Papers 24/13, HEDG, c/o Department of Economics, University of York.
- Oecd, 2024. "The OECD Truth Quest Survey: Methodology and findings," OECD Digital Economy Papers 369, OECD Publishing.
- Kuen-Suan Chen & Tsun-Hung Huang & Jin-Shyong Lin & Wen-Yang Kao & Wei Lo, 2024. "Fuzzy Testing Method of Process Incapability Index," Mathematics, MDPI, vol. 12(5), pages 1-11, February.
- Andreas Lundh & Marija Barbateskovic & Asbjørn Hróbjartsson & Peter C Gøtzsche, 2010. "Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study," PLOS Medicine, Public Library of Science, vol. 7(10), pages 1-7, October.
- Marcelo Ortiz & Caspar David Peter & Francisco Urzúa & Paolo F, 2023. "Mandatory Financial Disclosure and M&A Activity," The Review of Financial Studies, Society for Financial Studies, vol. 36(12), pages 4788-4823.
- Kristina M. L. Acri née Lybecker, 2024. "Health and biopharmaceutical innovation," Chapters, in: Walter G. Park (ed.), Handbook of Innovation and Intellectual Property Rights, chapter 23, pages 396-416, Edward Elgar Publishing.
- Rafael Company & Vera N. Egorova & Lucas Jódar, 2024. "An ETD Method for Vulnerable American Options," Mathematics, MDPI, vol. 12(4), pages 1-14, February.
- Anikó Bíró & Péter Elek, 2024. "Firm quality and health maintenance," IFS Working Papers W24/58, Institute for Fiscal Studies.
- Hneine Brax & Racha Fadlallah & Lina Al-Khaled & Lara A Kahale & Hala Nas & Fadi El-Jardali & Elie A Akl, 2017. "Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 12(4), pages 1-28, April.
- Kallestrup-Lamb, Malene & Marin, Alexander O.K. & Menon, Seetha & Søgaard, Jes, 2024. "Aging populations and expenditures on health," The Journal of the Economics of Ageing, Elsevier, vol. 29(C).
- Kristin Buske & Stefan Jentzsch & Clemens Bechter, 2016. "Is Self-Regulation Sufficient? Case of the German Transparency Code," Administrative Sciences, MDPI, vol. 6(1), pages 1-12, February.
- ., 2024. "Neighborhoods, health, and wellbeing," Chapters, in: Rethinking Neighborhoods, chapter 8, pages 149-165, Edward Elgar Publishing.
- Hamza Umer & Yanjun Li, 2024. "Positive and negative health events and trust," Empirica, Springer;Austrian Institute for Economic Research;Austrian Economic Association, vol. 51(2), pages 459-479, May.
- Les Mayhew & Mei Sum Chan & Andrew J. G. Cairns, 2024. "The great health challenge: levelling up the U.K," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 49(2), pages 270-294, April.
- Edward J. D. Webb & Paul Kind & David Meads & Adam Martin, 2024. "COVID-19 and EQ-5D-5L health state valuation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(1), pages 117-145, February.
- ., 2024. "The method and the schools," Chapters, in: New Developmentalism, chapter 1, pages 1-11, Edward Elgar Publishing.
- Li, Yanan & Sunder, Naveen, 2024. "Distributional effects of education on mental health," Labour Economics, Elsevier, vol. 88(C).
- ., 2024. "Theme 5: charting a new methods territory," Chapters, in: The Atlas of Social Complexity, chapter 27, pages 387-388, Edward Elgar Publishing.
- Heather Wood Ion, 2024. "Point of inflection: epidemic of health," Chapters, in: James R. Cochrane & Gary R. Gunderson & Teresa Cutts (ed.), Handbook on Religion and Health, chapter 11, pages 184-196, Edward Elgar Publishing.
- Ege Erdil & Tamay Besiroglu & Anson Ho, 2024. "Estimating Idea Production: A Methodological Survey," Papers 2405.10494, arXiv.org.
- Wenjing Xu & Zhi Li & Yudong Wang & KeJun Ma & Lu Liu & Yijun Bao & Xin Shi, 2024. "Public Health and Children’s Subjective Well-Being," Child Indicators Research, Springer;The International Society of Child Indicators (ISCI), vol. 17(4), pages 1471-1493, August.
- Mulinari, Shai & Martinon, Luc & Jachiet, Pierre-Alain & Ozieranski, Piotr, 2021. "Pharmaceutical industry self-regulation and non-transparency: country and company level analysis of payments to healthcare professionals in seven European countries," Health Policy, Elsevier, vol. 125(7), pages 915-922.
- Mark N.K. Saunders & Fariba Darabi, 2024. "Using multi- and mixed methods research designs," Chapters, in: Jane Parker & Noelle Donnelly & Sue Ressia & Mihajla Gavin (ed.), Field Guide to Researching Employment and Industrial Relations, chapter 4, pages 71-87, Edward Elgar Publishing.
- Oliver H. M. Yau & Bernard Lee, 2024. "Research Methodology," Springer Books, in: Chinese Marketing and Management Scales, chapter 0, pages 15-59, Springer.
- Ozaki, Akihiko & Saito, Hiroaki & Senoo, Yuki & Sawano, Toyoaki & Shimada, Yuki & Kobashi, Yurie & Yamamoto, Kana & Suzuki, Yosuke & Tanimoto, Tetsuya, 2020. "Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016," Health Policy, Elsevier, vol. 124(7), pages 727-735.
- Juan Wang & Xiao Li, 2024. "Environment, health, and safety," Chapters, in: Qiuchen Lu & Michael Pitt (ed.), Digital Built Asset Management, chapter 4, pages 67-104, Edward Elgar Publishing.
- Attila Gyetvai & Anikó Bíró & István Boza & Dániel Prinz, 2024. "Health Shocks, Social Insurance, and Firms," Working Papers w202411, Banco de Portugal, Economics and Research Department.
- Journal of Mathematics, 2024. "Retracted: Music Therapy Methods Based on SVM and MLP," Journal of Mathematics, Hindawi, vol. 2024, pages 1-1, January.
- Grundy, Quinn & Habibi, Roojin & Shnier, Adrienne & Mayes, Christopher & Lipworth, Wendy, 2018. "Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia," Health Policy, Elsevier, vol. 122(5), pages 509-518.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Moriarty, Frank & Larkin, James & Fahey, Tom, 2021. "Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study," Health Policy, Elsevier, vol. 125(10), pages 1297-1304.
- Mulinari, Shai & Pashley, Dylan & Ozieranski, Piotr, 2022. "Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark," Health Policy, Elsevier, vol. 126(12), pages 1256-1262.
- Anju Murayama & Yuki Senoo & Kayo Harada & Yasuhiro Kotera & Hiroaki Saito & Toyoaki Sawano & Yosuke Suzuki & Tetsuya Tanimoto & Akihiko Ozaki, 2022. "Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians," IJERPH, MDPI, vol. 19(6), pages 1-24, March.
- Mulinari, Shai & Martinon, Luc & Jachiet, Pierre-Alain & Ozieranski, Piotr, 2021. "Pharmaceutical industry self-regulation and non-transparency: country and company level analysis of payments to healthcare professionals in seven European countries," Health Policy, Elsevier, vol. 125(7), pages 915-922.
- Grant Lewison & Richard Sullivan, 2015. "Conflicts of interest statements on biomedical papers," Scientometrics, Springer;Akadémiai Kiadó, vol. 102(3), pages 2151-2159, March.
- Jacob Dut Chol Riak, 2024. "Understanding Oil Production: Investigating Factors Affecting the Oil Production Decline in Blocks 3 & 7 of South Sudan (2017-2022)," Journal of Scientific Reports, IJSAB International, vol. 7(1), pages 72-99.
- Shai Mulinari & Andreas Vilhelmsson & Emily Rickard & Piotr Ozieranski, 2020. "Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-19, June.
- Sand Salhout & Clemens Bechter, 2018. "The Middle East and Africa Code of Promotional Practices in the Pharmaceutical Industry," Administrative Sciences, MDPI, vol. 8(3), pages 1-13, September.
- Rachel Thompson & Zoe Paskins & Barry G. Main & Thaddeus Mason Pope & Evelyn C. Y. Chan & Ben W. Moulton & Michael J. Barry & Clarence H. Braddock III, 2021. "Addressing Conflicts of Interest in Health and Medicine: Current Evidence and Implications for Patient Decision Aid Development," Medical Decision Making, , vol. 41(7), pages 768-779, October.
- David Pontille & Didier Torny, 2013. "Behind the scenes of scientific articles: defining categories of fraud and regulating cases," CSI Working Papers Series 031, Centre de Sociologie de l'Innovation (CSI), Mines ParisTech.
- Vardakas, Konstantinos Z. & Tsopanakis, Grigorios & Poulopoulou, Alexandra & Falagas, Matthew E., 2015. "An analysis of factors contributing to PubMed's growth," Journal of Informetrics, Elsevier, vol. 9(3), pages 592-617.
- Harada, Kayo & Ozaki, Akihiko & Saito, Hiroaki & Sawano, Toyoaki & Yamamoto, Kana & Murayama, Anju & Senoo, Yuki & Tanimoto, Tetsuya, 2021. "Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017," Health Policy, Elsevier, vol. 125(3), pages 320-326.
- Anju Murayama & Akihiko Ozaki & Hiroaki Saito & Toyoaki Sawano & Yuki Shimada & Kana Yamamoto & Yosuke Suzuki & Tetsuya Tanimoto, 2020. "Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan," PLOS ONE, Public Library of Science, vol. 15(10), pages 1-16, October.
- Torsten Diekhoff & Peter Schlattmann & Marc Dewey, 2013. "Impact of Article Language in Multi-Language Medical Journals - a Bibliometric Analysis of Self-Citations and Impact Factor," PLOS ONE, Public Library of Science, vol. 8(10), pages 1-1, October.
- Ansari, Bahareh, 2021. "Industry payments and physicians prescriptions: Effect of a payment restriction policy," Social Science & Medicine, Elsevier, vol. 278(C).
- Mustafa Özer & Jan Fidrmuc, 2024. "Education and Mental Health: Causal Effects and Intra-Family Spillovers," CESifo Working Paper Series 11213, CESifo.
- Livio Garattini & Anna Padula, 2019. "Conflict of interest disclosure: striking a balance?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(5), pages 633-636, July.
- Light, Donald W. & Lexchin, Joel R., 2021. "Pharmaceuticals as a market for “lemons”: Theory and practice," Social Science & Medicine, Elsevier, vol. 268(C).
- Alawi A Alsheikh-Ali & Waqas Qureshi & Mouaz H Al-Mallah & John P A Ioannidis, 2011. "Public Availability of Published Research Data in High-Impact Journals," PLOS ONE, Public Library of Science, vol. 6(9), pages 1-4, September.
- Rickard, Emily & Ozieranski, Piotr & Mulinari, Shai, 2019. "Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK," Health Policy, Elsevier, vol. 123(12), pages 1244-1250.
More about this item
Keywords
Pharmaceutical industry; Conflict of interest; Transfers of value; Payments; Disclosures;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:149:y:2024:i:c:s0168851024001659. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.